Queen Mary University of London's Pedro Cutillas and colleagues from the UK describe phosphoproteomic analyses of cancer cell lines and potential applications of this information in the early, online edition of Genome Biology. When the researchers used mass spectrometry to assess phosphorylation levels at some 2,000 sites in nine cancer cell lines — three representatives apiece from acute myeloid leukemia, lymphoma, and multiple myeloma — they found that cell lines tended to cluster by cancer type.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

This Week in Nature

This Week in Cell

This Week in Nature

This Week in Nature

This Week in Cell

The New York Times' George Johnson muses on cancer's roots in multicellularity.

The San Diego Union Tribune wonders whether Medicare is ready for personalized medicine.

Jun Wang, the chief executive of BGI, has stepped down.

In PNAS this week: human T cell editing with CRISPR, retrotransposons acting as insulators, and more.